IO Biotech, Inc.
NASDAQ:IOBT
1 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.756 | 0.54 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.756 | -0.54 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 71.484 | 67.829 | 46.986 | 30.152 | 8.464 | 7.937 |
| General & Administrative Expenses
| 23.693 | 23.614 | 24.438 | 11.082 | 1.681 | 1.976 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 23.693 | 23.614 | 24.438 | 11.082 | 1.681 | 1.976 |
| Other Expenses
| 0 | 0 | 0 | -26.535 | -1.985 | -0.781 |
| Operating Expenses
| 95.177 | 91.443 | 71.424 | 41.234 | 10.145 | 9.913 |
| Operating Income
| -95.177 | -91.443 | -71.424 | -41.234 | -10.145 | -9.913 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.129 | 6.212 | 1.239 | -26.577 | -1.897 | -0.83 |
| Income Before Tax
| -94.048 | -85.231 | -70.185 | -67.811 | -12.042 | -10.743 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.443 | 0.852 | 1.273 | 0.068 | 0.026 | 0.006 |
| Net Income
| -95.491 | -86.083 | -71.458 | -67.879 | -12.068 | -10.749 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.45 | -1.98 | -2.48 | -2.36 | -0.42 | -0.37 |
| EPS Diluted
| -1.45 | -1.98 | -2.48 | -2.36 | -0.42 | -0.37 |
| EBITDA
| -93.199 | -91.228 | -69.343 | -67.45 | 0 | -0.824 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |